Journals / European Journal of Therapeutics / 2022 / Cilt: 28 - Sayı: 2

Manual Versus Automated Volume Reduction of Cord Blood

Pages
102–108
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: Our results showed that post-process total nucleated cell viability with CellEffic cord blood was slightly higher than Sepax, whereas Sepax post-process total nucleated cell/ mononuclear cell values were superior to CellEffic cord blood.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: All cord blood banks all over the world follow a common procedure, concentrating progenitor cells by volume reduction, with the main purpose of optimizing the use of storage space.
📊
Key Findings & Data:The main objective of this study was to compare CD34 and total nucleated cell recovery rates and red blood cell depletion efficiencies following cord blood processing using automated Sepax or manual CellEffic cord blood processing systems.
💡
Conclusion & Impact:Results: Our results showed that post-process total nucleated cell viability with CellEffic cord blood was slightly higher than Sepax, whereas Sepax post-process total nucleated cell/ mononuclear cell values were superior to CellEffic cord blood.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: All cord blood banks all over the world follow a common procedure, concentrating progenitor cells by volume reduction, with the main purpose of optimizing the use of storage space. The main objective of this study was to compare CD34 and total nucleated cell recovery rates and red blood cell depletion efficiencies following cord blood processing using automated Sepax or manual CellEffic cord blood processing systems. Methods: Nine cord blood units with high volumes were divided into 2 equal fractions and processed with CellEffic cord blood and Sepax. Total nucleated cell, mononuclear cells, CD34+, red blood cell and total nucleated cell viability, and clonogenic assays were performed, and recovery rates were calculated on pre- and post-process cord blood units and after freeze/thaw process. In the comparison group, post-thaw differential cell counting was also performed. Results: Our results showed that post-process total nucleated cell viability with CellEffic cord blood was slightly higher than Sepax, whereas Sepax post-process total nucleated cell/ mononuclear cell values were superior to CellEffic cord blood. Postthaw red blood cell depletion was better for CellEffic cord blood. Post-thaw Sepax colony-forming unit counts were higher than CellEffic cord blood. In addition, CD45+CD71+ cells were lower, whereas CD45+CD34+CD38− cells were higher for the CellEffic cord blood system. Conclusion: Despite the fact that there is a need for well-trained personnel for processing cord blood units with CellEffic cord blood, it may be an attractive alternative to Sepax system for cord blood processing, particularly for cord blood units with low volumes, at banks with low budget where the cord blood turnover rates are relatively low.

🔖

Cite This Article

AKIN, H. Y., ÖNCÜL, E. B. G., BEKSAÇ, M., MESUTOĞLU, P. Y. (2022). Manual Versus Automated Volume Reduction of Cord Blood. European Journal of Therapeutics, Cilt: 28 - Sayı: 2, 102–108. https://ajindex.com/articles/512095

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Munoz J, Shah N, Rezvani K, et al. Concise review: umbilical cord blood transplantation: past, present, and future. Stem Cells Transl Med. 2014
  2. 3(12):1435-1443. [CrossRef] 2. Querol S, Samarkanova D. Rapid review: next generation of cord blood banks
  3. transplantation and beyond. Transfusion. 2019
  4. 59(10): 3048-3050. [CrossRef] 3. Mayani H, Wagner JE, Broxmeyer HE. Cord blood research, banking, and transplantation: achievements, challenges, and perspectives. Bone Marrow Transplant. 2020
  5. 55(1):48-61. [CrossRef] 4. Bhandari R, Lindley A, Bhatla D, et al. Awareness of cord blood collection and the impact on banking. Pediatr Blood Cancer. 2017
  6. 64(7). [CrossRef] 5. Little AM. HLA antibodies in haematopoietic stem cell transplantation. HLA. 2019
  7. 94(suppl 2):21-24. [CrossRef] 6. Pasha R, Halpenny M, Pineault N. Overcoming the deceptively low viability of CD45(+) cells in thawed cord blood unit segments. Vox Sang. 2019
  8. 114(8):876-883. [CrossRef] 7. Armitage S. Cord blood banking standards: autologous Versus altruistic. Front Med (Lausanne). 2015
  9. [CrossRef] 8. Murphy A, McKenna D, McCullough J. Cord blood banking and quality issues. Transfusion. 2016
  10. 56(3):645-652. [CrossRef] 9. Wall DA. Issues in the quality of umbilical cord blood stem cells for transplantation: challenges in cord blood banking quality management. Transfusion. 2005
  11. 45(6):826-828. [CrossRef] 10. Basford C, Forraz N, Habibollah S, Hanger K, McGuckin C. The cord blood separation league table: a comparison of the major clinical grade harvesting techniques for cord blood stem cells. Int J Stem Cells. 2010
  12. 3(1):32-45. [CrossRef] 11. Souri M, Nikougoftar Zarif M, Rasouli M, et al. Comparison of human umbilical cord blood processing with or without hydroxyethyl starch. Transfusion. 2017
  13. 57(11):2758-2766. [CrossRef] 12. Solves P, Planelles D, Mirabet V, Blanquer A, Carbonell-Uberos F. Qualitative and quantitative cell recovery in umbilical cord blood processed by two automated devices in routine cord blood banking: a comparative study. Blood Transfus. 2013
  14. 11(3):405-411. [CrossRef] 13. Kim KM, Huh JY, Kim JJ, Kang MS. Quality comparison of umbilical cord blood cryopreserved with conventional versus automated systems. Cryobiology. 2017
  15. [CrossRef] 14. Sowemimo-Coker SO, Andrade F, Kim A, Pesci S. A simple filtration system for red blood cell depletion and volume reduction in routine processing of human umbilical cord blood. Vox Sang. 2009
  16. 96(2):138- 145. [CrossRef] 15. Sowemimo-Coker S